Amanote Research
Register
Sign In
MIR-491: CDKN2A Tumor Suppressor Co-Pilot
Oncoscience
- United States
doi 10.18632/oncoscience.201
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 21, 2015
Authors
Unknown
Publisher
Impact Journals, LLC
Related search
Tumor Suppressor Role of miR-3622b-5p in ERBB2-positive Cancer
Oncotarget
Oncology
The Tumor Suppressor miR-138-5p Targets PD-L1 in Colorectal Cancer
Oncotarget
Oncology
miR-23b* Targets Proline Oxidase, a Novel Tumor Suppressor Protein in Renal Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
miR‑381 Functions as a Tumor Suppressor by Targeting ETS1 in Pancreatic Cancer
International Journal of Molecular Medicine
Medicine
Genetics
Pro-Neural miR-128 Is a Glioma Tumor Suppressor That Targets Mitogenic Kinases
Oncogene
Cancer Research
Genetics
Molecular Biology
miR-203, a Tumor Suppressor Frequently Down-Regulated by Promoter Hypermethylation in Rhabdomyosarcoma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
miR-335 Acts as a Tumor Suppressor and Enhances Ionizing Radiation-Induced Tumor Regression by Targeting ROCK1
Frontiers in Oncology
Cancer Research
Oncology
miR-92b-3p Acts as a Tumor Suppressor by Targeting Gabra3 in Pancreatic Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
miR-148b-3p Functions as a Tumor Suppressor in GISTs by Directly Targeting KIT
Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology